JPMorgan Chase & Co. Issues Positive Forecast for Victrex (LON:VCT) Stock Price

Victrex (LON:VCT) had its target price raised by analysts at JPMorgan Chase & Co. from GBX 625 to GBX 785 in a research note issued to investors on Thursday, London Stock Exchange reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential downside of 21.68% from the stock’s current price.

Several other equities research analysts have also issued reports on the stock. Berenberg Bank increased their target price on shares of Victrex from GBX 600 to GBX 680 and gave the stock a “hold” rating in a report on Wednesday, July 8th. Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 595 price target on shares of Victrex in a report on Tuesday, July 7th. Finally, Canaccord Genuity Group lowered shares of Victrex to a “buy” rating and set a GBX 725 price target for the company. in a research report on Friday, May 15th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Victrex presently has an average rating of “Hold” and a consensus target price of GBX 690.

Victrex Stock Down 0.8%

LON VCT opened at GBX 1,002.34 on Thursday. The stock’s 50-day moving average price is GBX 777.33 and its 200-day moving average price is GBX 671.57. The company has a quick ratio of 1.99, a current ratio of 2.35 and a debt-to-equity ratio of 21.30. Victrex has a 52 week low of GBX 515 and a 52 week high of GBX 1,024. The company has a market capitalization of £873.60 million, a P/E ratio of -44.75, a price-to-earnings-growth ratio of 1.92 and a beta of 0.82.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.